EuRBPDB

Note: to get the extension of tumor abbreviations.

Cancer Related Information
Basic Information

Cancer associated literatures

PID	Title	Article	Time	Author	Doi
21664646	Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.	Hum Pathol	2011 Dec	Karamitopoulou E	doi: 10.1016/j.humpath.2010.06.020
22662230	Regulation of RKIP function by Helicobacter pylori in gastric cancer.	PLoS One	2012	Moen EL	doi: 10.1371/journal.pone.0037819
22809510	MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells.	Biochem Biophys Res Commun	2012 Aug 24	Huang L	doi: 10.1016/j.bbrc.2012.07.025
23066640	Decreased expression and aberrant methylation of Raf kinase inhibitory protein gene in esophageal squamous cell carcinoma.	Cancer Invest	2012 Dec	Guo W	doi: 10.3109/07357907.2012.732164
25764514	Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.	Gastric Cancer	2016 Apr	Chen Y	doi: 10.1007/s10120-015-0485-0
26238785	Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.	Cancer Res	2015 Oct 1	Frankenberger C	doi: 10.1158/0008-5472.CAN-14-3394
29315556	KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer.	Int J Cancer	2018 Jun 1	Yang K	doi: 10.1002/ijc.31248
25277181	Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma.	Oncotarget	2014 Sep 15	Hill B	-
25597355	Survey of Raf kinase inhibitor protein (RKIP) in multiple cancer types.	Crit Rev Oncog	2014	Lamiman K	-
23376254	Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathway.	Cancer Lett	2013 Jul 10	Schoppmann SF	doi: 10.1016/j.canlet.2013.01.044
24330423	Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC).	J Transl Med	2013 Dec 14	Karamitopoulou E	doi: 10.1186/1479-5876-11-311.
20739083	PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection.	J Hepatol	2010 Nov	Xu YF	doi: 10.1016/j.jhep.2010.05.019
17911631	Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.	J Immunol	2007 Oct 15	Baritaki S	-
24048798	Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma.	Cancer	2011 Jun 1	Maresch J	doi: 10.1002/cncr.25799
26375811	RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.	Oncotarget	2015 Nov 17	Datar I	doi: 10.18632/oncotarget.5176.
27902472	Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression.	Oncotarget	2017 Jan 3	Cheng XK	doi: 10.18632/oncotarget.13586.
29930472	Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.	World J Gastroenterol	2018 Jun 21	Wang Y	doi: 10.3748/wjg.v24.i23.2508.
19291429	Immunohistochemical detection of the Raf kinase inhibitor protein in nonneoplastic gastric tissue and gastric cancer tissue.	Med Oncol	2010 Jun	Wang J	doi: 10.1007/s12032-009-9194-z
21672326	Immunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissue.	J Int Med Res	2011	Hu CJ	-
22463874	Prognostic value of RKIP and p-ERK in gastric cancer.	J Exp Clin Cancer Res	2012 Mar 31	Fujimori Y	doi: 10.1186/1756-9966-31-30.
21180766	RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility.	Mol Biosyst	2011 Mar	al-Mulla F	doi: 10.1039/c0mb00208a
17145707	Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells.	Nucleic Acids Res	2006	Molinaro RJ	-
25597354	Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer.	Crit Rev Oncog	2014	Yesilkanal AE	-
20869966	Development and evaluation of monoclonal antibodies against phosphatidylethanolamine binding protein 1 in pancreatic cancer patients.	J Immunol Methods	2010 Oct 31	Wang X	doi: 10.1016/j.jim.2010.09.026
24658061	Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.	PLoS One	2014 Mar 21	Yousuf S	doi: 10.1371/journal.pone.0092478
26238523	Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancer.	Oncol Rep	2015 Oct	Wang Y	doi: 10.3892/or.2015.4157
25337233	Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.	Int J Clin Exp Pathol	2014 Aug 15	Zhang XM	-
22460832	RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases.	Clin Exp Metastasis	2012 Aug	Birner P	doi: 10.1007/s10585-012-9470-8
15327891	Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis.	Adv Cancer Res	2004	Odabaei G	-
22295570	RKIp inhibits the migration and invasion of human prostate cancer PC-3M cells through regulation of extracellular matrix.	Mol Biol (Mosk)	2011 Nov-Dec	Xinzhou H	-
22505648	Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.	Cancer Res	2012 Jun 15	Ren G	doi: 10.1158/0008-5472.CAN-11-3546
27444299	Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.	J Cancer Res Clin Oncol	2016 Oct	Dai H	doi: 10.1007/s00432-016-2206-4
18375747	Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability.	J Clin Pathol	2008 Apr	Al-Mulla F	doi: 10.1136/jcp.2007.046987.
20853079	Implication of RAF and RKIP genes in urinary bladder cancer.	Pathol Oncol Res	2011 Jun	Zaravinos A	doi: 10.1007/s12253-010-9295-1
26177829	Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine.	J Biomed Sci	2015 Jul 16	Nie F	doi: 10.1186/s12929-015-0162-y.
21303975	Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β.	Cancer Res	2011 Feb 15	Al-Mulla F	doi: 10.1158/0008-5472.CAN-10-3102
17952120	Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.	Oncogene	2008 Apr 3	Beach S	-
23975428	RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2.	Oncogene	2014 Jul 3	Sun M	doi: 10.1038/onc.2013.328
24395801	Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions.	Proc Natl Acad Sci U S A	2014 Jan 21	Lee J	doi: 10.1073/pnas.1304840111
16243812	Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.	Clin Cancer Res	2005 Oct 15	Hagan S	-
18172264	Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.	Clin Cancer Res	2008 Jan 1	Zlobec I	doi: 10.1158/1078-0432.CCR-07-1380.
25597353	RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-??B/Snail/YY1/RKIP resistance-driver loop.	Crit Rev Oncog	2014	Bonavida B	-
24123286	Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.	J Cell Biochem	2014 Mar	Al-Mulla F	doi: 10.1002/jcb.24682.
22248055	The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-??B/Snail/YY1/RKIP/PTEN Circuitry.	Crit Rev Oncog	2011	Bonavida B	-
19957553	[Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].	Zhonghua Fu Chan Ke Za Zhi	2009 Jul	Wang Y	-
25597352	Genetic and epigenetic control of RKIP transcription.	Crit Rev Oncog	2014	Datar I	-
22855160	Reduced expression of Raf kinase inhibitor protein correlates with poor prognosis in pancreatic cancer.	Clin Transl Oncol	2012 Nov	Song SP	doi: 10.1007/s12094-012-0870-7
22899242	RKIP and 14-3-3?? exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently.	Dig Dis Sci	2013 Feb	Yan L	doi: 10.1007/s10620-012-2341-y
23674108	Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.	Oncol Rep	2013 Jul	Zhao D	doi: 10.3892/or.2013.2464
17179102	Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.	J Clin Oncol	2006 Dec 20	Al-Mulla F	-
18567796	Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.	Mol Cancer Res	2008 Jun	Li HZ	doi: 10.1158/1541-7786.MCR-08-0093.
25172097	RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN.	Tumour Biol	2014 Dec	Liu H	doi: 10.1007/s13277-014-2486-8
26308852	RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.	PLoS One	2015 Aug 26	Datar I	doi: 10.1371/journal.pone.0134494
25547433	RKIP promotes cisplatin-induced gastric cancer cell death through NF-??B/Snail pathway.	Tumour Biol	2015 Mar	Liu H	doi: 10.1007/s13277-014-2496-6
19779262	[Expression of Raf kinase inhibitor protein and E-cadherin in prostate cancer tissues].	Zhong Nan Da Xue Xue Bao Yi Xue Ban	2009 Sep	Lu S	-
23527098	RKIP inhibition in cervical cancer is associated with higher tumor aggressive behavior and resistance to cisplatin therapy.	PLoS One	2013	Martinho O	doi: 10.1371/journal.pone.0059104
22246605	RKIP expression associated with gastric cancer cell invasion and metastasis.	Tumour Biol	2012 Aug	Jia B	doi: 10.1007/s13277-012-0317-3
27651238	RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.	Arch Biochem Biophys	2016 Nov 15	Zou Q	doi: 10.1016/j.abb.2016.09.007
28245474	MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.	Cell Physiol Biochem	2017	Du Y	doi: 10.1159/000464120
28418894	Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.	Oncotarget	2017 Jun 20	Papale M	doi: 10.18632/oncotarget.16341.
29990987	Somatostatin Octapeptide Inhibits Cell Invasion and Metastasis in Hepatocellular Carcinoma Through PEBP1.	Cell Physiol Biochem	2018	Huang CZ	doi: 10.1159/000491540

Differential Expression

Expression in 33 cancers

Mutations

Cancer	Chr	Position	Mutation Type	dbSNP	Protein-change	Allele Freq
BLCA	chr12	118144590	Silent	novel	L117L	0.33
BRCA	chr12	118144679	Missense_Mutation	NA	G147V	0.2
COAD	chr12	118144740	Silent	rs146924072	T167T	0.25
COAD	chr12	118139531	Missense_Mutation	rs768506934	S109L	0.06
ESCA	chr12	118144860	3'UTR	novel		0.16
GBM	chr12	118144746	Frame_Shift_Del	novel	*Q170Rfs43**	0.04
GBM	chr12	118138087	Missense_Mutation	novel	K62Q	0.12
HNSC	chr12	118139496	Silent	novel	I97I	0.22
HNSC	chr12	118144884	3'UTR	novel		0.19
KIRP	chr12	118139528	Missense_Mutation	NA	G108D	0.41
KIRP	chr12	118139527	Missense_Mutation	NA	G108C	0.16
KIRP	chr12	118138143	Missense_Mutation	NA	K80N	0.33
LAML	chr12	118139505	Silent	novel	G100G	0.42
LIHC	chr12	118139530	Missense_Mutation	novel	S109T	0.42
LUAD	chr12	118138075	Missense_Mutation	NA	L58V	0.09
LUAD	chr12	118139533	Missense_Mutation	NA	G110W	0.27
LUSC	chr12	118144878	3'UTR	novel		0.2
LUSC	chr12	118138113	Frame_Shift_Del	novel	*P71Rfs22**	0.11
OV	chr12	118138075	Missense_Mutation	NA	L58V	0.39
PCPG	chr12	118144826	3'UTR	novel		0.1
SARC	chr12	118136284	Silent	novel	L25L	0.13
SARC	chr12	118144826	3'UTR	novel		0.26
SKCM	chr12	118139516	Missense_Mutation	novel	S104F	0.39
SKCM	chr12	118144701	Silent	novel	F154F	0.2
SKCM	chr12	118138139	Missense_Mutation	novel	P79L	0.27
SKCM	chr12	118144674	Silent	NA	H145H	0.56
SKCM	chr12	118144867	3'UTR	novel		0.19
SKCM	chr12	118144624	Missense_Mutation	NA	R129G	0.27
SKCM	chr12	118139516	Missense_Mutation	novel	S104F	0.25
STAD	chr12	118139457	Nonsense_Mutation	novel	W84*	0.1
UCEC	chr12	118138064	Missense_Mutation	rs373019765	S54L	0.28
UCEC	chr12	118144586	Missense_Mutation	rs777648257	G116D	0.29
UCEC	chr12	118144884	3'UTR	novel		0.45
UCEC	chr12	118144785	Silent	novel	E182E	0.1
UCEC	chr12	118144661	Missense_Mutation	rs530714085	R141Q	0.29
UCEC	chr12	118144764	Silent	rs779966169	D175D	0.52
UCEC	chr12	118144661	Missense_Mutation	rs530714085	R141Q	0.44
UCEC	chr12	118139480	Missense_Mutation	novel	M92T	0.59
UCEC	chr12	118144780	Missense_Mutation	novel	Y181H	0.25
UCEC	chr12	118136255	Nonsense_Mutation	novel	E16*	0.5
UCEC	chr12	118144879	3'UTR	novel		0.3
UCEC	chr12	118138065	Silent	rs749610406	S54S	0.34

Copy Number Variations (CNVs)

Cancer	Type	Freq	Q-value
CHOL	DEL	0.2222	0.067545
HNSC	DEL	0.0536	0.22646
LUAD	DEL	0.1357	0.0059643
LUSC	DEL	0.1098	0.038823
PAAD	DEL	0.1902	0.0030251
PRAD	AMP	0.065	0.016187
SKCM	DEL	0.188	0.00079981

Survival Analysis

Cancer	P-value	Q-value
KIRC	0.00011	Kaplan-Meier Survival Analysis
MESO	0.0023	Kaplan-Meier Survival Analysis
SKCM	0.028	Kaplan-Meier Survival Analysis
KIRP	0.00025	Kaplan-Meier Survival Analysis
PAAD	0.0026	Kaplan-Meier Survival Analysis
CESC	0.001	Kaplan-Meier Survival Analysis
UCEC	0.0083	Kaplan-Meier Survival Analysis
LIHC	0.013	Kaplan-Meier Survival Analysis
LGG	0.039	Kaplan-Meier Survival Analysis
LUAD	0.0001	Kaplan-Meier Survival Analysis
UVM	0.00058	Kaplan-Meier Survival Analysis
OV	0.04	Kaplan-Meier Survival Analysis

Drugs

Cell lines and drugs in GSE70138 or GSE92742

Description

RBPome

Literatures

Expression

Transcripts

Gene Model

PPI

Gene Ontology

Description

Ensembl ID: ENSG00000089220 (Gene tree)
Gene ID: 5037
Gene Symbol: PEBP1
Alias: RKIP|HCNP|PEBP|PBP
Full Name: phosphatidylethanolamine binding protein 1
Gene Type: protein_coding
Species: Homo_sapiens
Status: confidence
Strand: Plus strand
Length: 9,728 bases
Position: chr12:118,135,858-118,145,585
Accession: 8630
RBP type: non-canonical RBP
Summary: This gene encodes a member of the phosphatidylethanolamine-binding family of proteins and has been shown to modulate multiple signaling pathways, including the MAP kinase (MAPK), NF-kappa B, and glycogen synthase kinase-3 (GSK-3) signaling pathways. The encoded protein can be further processed to form a smaller cleavage product, hippocampal cholinergic neurostimulating peptide (HCNP), which may be involved in neural development. This gene has been implicated in numerous human cancers and may act as a metastasis suppressor gene. Multiple pseudogenes of this gene have been identified in the genome. [provided by RefSeq, Jul 2015]

RNA binding proteome (RBPome)

PID	Title	Method	Time	Author	Doi
22681889	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts	4SURIC & HEK293	2012 May	Baltz AG	DOI: 10.1016/j.molcel.2012.05.021
30607034	Comprehensive identification of RNA protein interactions in any organism using orthogonal organic phase separation (OOPS)	OOPS & HEK293	2019 Jan 3	Queiroz RML	DOI: 10.1038/s41587-018-0001-2
30528433	The Human RNA-Binding Proteome and Its Dynamics during Translational Arrest	XRNAX & HEK293	2018 Dec 6	Trendel J	DOI: 10.1016/j.cell.2018.11.004
29431736	Capturing the interactome of newly transcribed RNA	RIC & Hela	2018 Feb 12	Bao X	DOI: 10.1038/nmeth.4595
22658674	Insights into RNA biology from an atlas of mammalian mRNA-binding proteins	RIC & Hela	2012 May 31	Castello A	DOI: 10.1016/j.cell.2012.04.031
30528433	The Human RNA-Binding Proteome and Its Dynamics during Translational Arrest	XRNAX & Hela	2018 Dec 6	Trendel J	DOI: 10.1016/j.cell.2018.11.004
30607034	Comprehensive identification of RNA protein interactions in any organism using orthogonal organic phase separation (OOPS)	OOPS & MCF10A	2019 Jan 3	Queiroz RML	DOI: 10.1038/s41587-018-0001-2
30528433	The Human RNA-Binding Proteome and Its Dynamics during Translational Arrest	XRNAX & MCF7	2018 Dec 6	Trendel J	DOI: 10.1016/j.cell.2018.11.004
30607034	Comprehensive identification of RNA protein interactions in any organism using orthogonal organic phase separation (OOPS)	OOPS & U2OS	2019 Jan 3	Queiroz RML	DOI: 10.1038/s41587-018-0001-2
27453046	Comprehensive Identification of RNA-Binding Domains in Human Cells	RIC & Hela	2016 Aug 18	Castello A	DOI: 10.1016/j.molcel.2016.06.029

Literatures on RNA binding capacity

PID	Title	Article	Time	Author	Doi
31231308	The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas.	Front Endocrinol (Lausanne)	2019 May 22	Lu M	doi: 10.3389/fendo.2019.00330
6171302	Reduction of prostatic binding protein-messenger ribonucleic acid sequences in rat prostate by castration.	Biochemistry	1981 Nov 10	Hiremath ST	-
7391065	Androgen-induced messenger RNA in rat ventral prostate. Translation, partial purification, and preliminary characterization of the mRNAs encoding the components of prostatic binding protein.	J Biol Chem	1980 Jul 25	Peeters BL	-
6646114	Androgen regulation of prostatic binding protein messenger RNA studied by using cloned complementary DNA.	Mol Cell Biochem	1983	Mpanias OD	-
15133065	Maternal nutrient restriction alters gene expression in the ovine fetal heart.	J Physiol	2004 Jul 1	Han HC	-
17145707	Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells.	Nucleic Acids Res	2006	Molinaro RJ	-

Expression

Transcripts

Transcript ID	Name	Length	RefSeq ID	Protein ID	Length	RefSeq ID	UniportKB ID
ENST00000261313	PEBP1-201	1697	-	ENSP00000261313	187 (aa)	-	P30086
ENST00000542939	PEBP1-202	708	-	-	- (aa)	-	-

Gene Model

Click here to download ENSG00000089220's gene model file

Protein-Protein Interaction (PPI)

Clik here to download ENSG00000089220's network

* RBP PPI network refers to all genes directly bind to RBP

Gene Ontology

Go ID	Go_term	PubmedID	Evidence	Category
GO:0000165	MAPK cascade	21873635.	IBA	Process
GO:0000165	MAPK cascade	-	TAS	Process
GO:0001505	regulation of neurotransmitter levels	21873635.	IBA	Process
GO:0002026	regulation of the force of heart contraction	21873635.	IBA	Process
GO:0003723	RNA binding	22658674.	HDA	Function
GO:0004867	serine-type endopeptidase inhibitor activity	-	IEA	Function
GO:0005102	signaling receptor binding	21873635.	IBA	Function
GO:0005515	protein binding	17097642.21831839.30337686.	IPI	Function
GO:0005524	ATP binding	21873635.	IBA	Function
GO:0005615	extracellular space	21873635.	IBA	Component
GO:0005634	nucleus	21630459.	HDA	Component
GO:0005739	mitochondrion	21873635.	IBA	Component
GO:0005741	mitochondrial outer membrane	21873635.	IBA	Component
GO:0005794	Golgi apparatus	21873635.	IBA	Component
GO:0005829	cytosol	-	TAS	Component
GO:0006979	response to oxidative stress	21873635.	IBA	Process
GO:0007568	aging	21873635.	IBA	Process
GO:0008021	synaptic vesicle	21873635.	IBA	Component
GO:0008429	phosphatidylethanolamine binding	7637590.	TAS	Function
GO:0009408	response to heat	21873635.	IBA	Process
GO:0009611	response to wounding	21873635.	IBA	Process
GO:0009636	response to toxic substance	21873635.	IBA	Process
GO:0009986	cell surface	21873635.	IBA	Component
GO:0010243	response to organonitrogen compound	21873635.	IBA	Process
GO:0010951	negative regulation of endopeptidase activity	-	IEA	Process
GO:0014823	response to activity	21873635.	IBA	Process
GO:0019899	enzyme binding	21831839.	IPI	Function
GO:0019901	protein kinase binding	21831839.	IPI	Function
GO:0021766	hippocampus development	21873635.	IBA	Process
GO:0043025	neuronal cell body	21873635.	IBA	Component
GO:0043209	myelin sheath	21873635.	IBA	Component
GO:0043409	negative regulation of MAPK cascade	21873635.	IBA	Process
GO:0043679	axon terminus	21873635.	IBA	Component
GO:0043950	positive regulation of cAMP-mediated signaling	21873635.	IBA	Process
GO:0045177	apical part of cell	21873635.	IBA	Component
GO:0045471	response to ethanol	21873635.	IBA	Process
GO:0045840	positive regulation of mitotic nuclear division	21873635.	IBA	Process
GO:0048240	sperm capacitation	21873635.	IBA	Process
GO:0051019	mitogen-activated protein kinase binding	21873635.	IBA	Function
GO:0051412	response to corticosterone	21873635.	IBA	Process
GO:0051591	response to cAMP	21873635.	IBA	Process
GO:0051592	response to calcium ion	21873635.	IBA	Process
GO:0060409	positive regulation of acetylcholine metabolic process	21873635.	IBA	Process
GO:0070062	extracellular exosome	19056867.19199708.20458337.23533145.	HDA	Component

EuRBPDB

Note: to get the extension of tumor abbreviations.

Select Dataset :

Input Drug :

Input Cell Line :

Eesembl ID

Cell lines and drugs in GSE70138 or GSE92742

Description

RBPome

Literatures

Expression

Transcripts

Gene Model

PPI

Gene Ontology

Note: Click here to get the extension of tumor abbreviations.

Select Dataset :

Input Drug :

Input Cell Line :

Eesembl ID

Cell lines and drugs in GSE70138 or GSE92742

Note: to get the extension of tumor abbreviations.